Company news
Black Diamond Therapeutics, Inc. news in 2026
Black Diamond Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 5, 2026
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 21, 2026
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
May 19, 2026
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
April 20, 2026
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 16, 2026
Convergent Therapeutics Appoints Elizabeth L. Montgomery Chief People Officer
January 28, 2026